Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Raisch

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
American Journal of Hospital Pharmacy|April 1, 1988
Association of length of stay and total hospital charges with antimicrobial regimen changesD W Raisch, J L Bootman, W F McGhan
The New England Journal of Medicine|August 12, 2000
"We don't carry that"M T Holdsworth, J R Anderson, D W Raisch
Hospital Formulary|July 9, 1986
The effects of DRGs and cost-containment: assessment by hospital pharmacy directorsW F McGhan, L N Larson, D W Raisch
Journal of Pharmaceutical Marketing & Management|December 10, 1988
Pharmacy participation in third-party contracts: decision making through economic and financial analysisD W Raisch, L N Larson, J L Bootman
DICP : the Annals of Pharmacotherapy|July 1, 1991
Evaluation of a non-Food and Drug Administration-approved use of cimetidine: treatment of pruritus resulting from epidural morphine analgesiaD W Raisch, A D Barreuther, R C Osborne
Prostate Cancer and Prostatic Diseases|February 13, 2013
Health disparities in clinical practice patterns for prostate cancer screening by geographic regions in the United States: a multilevel modeling analysisV Garg, D W Raisch, J P Selig, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 26, 1998
Effect of a pharmacist-education initiative on ketorolac use and costs in a Medicaid programD W Raisch, R W Hammond, J L Hollarbush, et al.
Expert Opinion on Drug Safety|June 8, 2019
Comparison of post-marketing surveillance approaches regarding infections related to tumor necrosis factor inhibitors (TNFi's) used in treatment of autoimmune diseasesC Chen, M E Borrego, M H Roberts, et al.
Journal of Pediatric Hematology/Oncology|April 25, 2000
Survey ranking of emetogenic control in children receiving chemotherapyB E Small, M T Holdsworth, D W Raisch, et al.
American Journal of Hospital Pharmacy|August 1, 1990
Improving antiulcer agent prescribing in a health maintenance organizationD W Raisch, J L Bootman, L N Larson, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
American Journal of Hospital Pharmacy|April 1, 1988
Association of length of stay and total hospital charges with antimicrobial regimen changesD W Raisch, J L Bootman, W F McGhan
The New England Journal of Medicine|August 12, 2000
"We don't carry that"M T Holdsworth, J R Anderson, D W Raisch
Hospital Formulary|July 9, 1986
The effects of DRGs and cost-containment: assessment by hospital pharmacy directorsW F McGhan, L N Larson, D W Raisch
Journal of Pharmaceutical Marketing & Management|December 10, 1988
Pharmacy participation in third-party contracts: decision making through economic and financial analysisD W Raisch, L N Larson, J L Bootman
DICP : the Annals of Pharmacotherapy|July 1, 1991
Evaluation of a non-Food and Drug Administration-approved use of cimetidine: treatment of pruritus resulting from epidural morphine analgesiaD W Raisch, A D Barreuther, R C Osborne
Prostate Cancer and Prostatic Diseases|February 13, 2013
Health disparities in clinical practice patterns for prostate cancer screening by geographic regions in the United States: a multilevel modeling analysisV Garg, D W Raisch, J P Selig, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 26, 1998
Effect of a pharmacist-education initiative on ketorolac use and costs in a Medicaid programD W Raisch, R W Hammond, J L Hollarbush, et al.
Expert Opinion on Drug Safety|June 8, 2019
Comparison of post-marketing surveillance approaches regarding infections related to tumor necrosis factor inhibitors (TNFi's) used in treatment of autoimmune diseasesC Chen, M E Borrego, M H Roberts, et al.
Journal of Pediatric Hematology/Oncology|April 25, 2000
Survey ranking of emetogenic control in children receiving chemotherapyB E Small, M T Holdsworth, D W Raisch, et al.
American Journal of Hospital Pharmacy|August 1, 1990
Improving antiulcer agent prescribing in a health maintenance organizationD W Raisch, J L Bootman, L N Larson, et al.
Pageof 4